6. She was followed in the pediatric
neurology outpatient clinic as a case
of periodic paralysis.
Few months later, she developed a
similar attack of quadriparesis.
8. So….So….
The main abnormality is “hypokalemicThe main abnormality is “hypokalemic
metabolic alkalosis withmetabolic alkalosis with ↑↑ urine chloride”.urine chloride”.
16. BartterBartter
SyndromeSyndrome
• Autosomal recessive renal tubular disorderAutosomal recessive renal tubular disorder
characterized by hypokalemia,characterized by hypokalemia,
hypocholermia, metabolic alkalosis,hypocholermia, metabolic alkalosis,
hyperreninemia with normal blood pressure,hyperreninemia with normal blood pressure,
decreased pressor responsiveness to infuseddecreased pressor responsiveness to infused
angiotensin II, and hyperplasia of theangiotensin II, and hyperplasia of the
juxtaglomerular complex.juxtaglomerular complex.Bartter FC, Et al., Am J Med 33:811-828, 1962Bartter FC, Et al., Am J Med 33:811-828, 1962..
23. Lumen
Ca2+
, Mg2+
, Na+
, NH4
+
Na+
2Cl-
K+
K+
Lumen (+)
voltage
Ca++
furosemide
TRPV4
ROMK
KCNJ1
ATP
Cl-
3Na+
2K+
ClC-Kb
Barttin
Blood
Paracellin-1
+8 mV
Cl-
ClC-Ka ?
CaSR
NKCC2
SLC12A1
Bartter syndromeBartter syndrome
type I
type II type III
type IV
type V
25. Bartter SyndromeBartter Syndrome
ClassificationClassification
O Neonatal Bartter syndrome.
O Classic Bartter syndrome.
O Gitelman syndrome.
Bartter Syndrome Genotype-Phenotype Correlations
Genetic Type Defective Gene Clinical Type
Bartter type I NKCC2 Neonatal
Bartter type II ROMK Neonatal
Bartter type III CLCNKB Classic
Bartter type IV BSND Neonatal with deafness
Bartter type V CLCNKB and CLCNKA Neonatal with deafness
Gitelman syndrome NCCT Gitelman syndrome
26. A) Hypokalemic metabolic alkalosis.
B) Hypercalciuria.
C) Activated RAAS + Normal blood
pressure.
D) Diminished serum PGE2 level.
All the following are true ofAll the following are true of
Bartter Syndrome EXCEPTBartter Syndrome EXCEPT
Na+
2Cl-
K+
↓K, volume contraction & ↑ANII →↑
entrarenal BGE2 → vicious cercal →
growth retardation and hyperplasia,
juxtaglomerular complex
Lumen
Ca2+
, Mg2+
,
Na+
, NH4
+
Na+
2Cl-
K+
K+
Lumen (+)
voltage
C
a
++
furosemide
TRPV4
ROMK
KCNJ1
ATP
Cl-
3Na+
2K+
ClC-Kb
Barttin
Bloo
d
Paracellin-1
+8 mV
Cl-
ClC-
Ka
?
CaSR
NKCC2
SLC12A1
27. The following Lab abnormalities are presentThe following Lab abnormalities are present
in patients with Gitelman syndrome:in patients with Gitelman syndrome:
A) Hypercalciuria
B) Hypomagnesemia
C) Increased urinary prostaglandins
D) Normal plasma renin activity
ATP
3Na+
2K+
Na+
Cl-
Ca++
Na+
Ca++
ECaC1
TRPV5
Cl-
ClC-Kb
Barttin
NCCT
thiazide
NCX1
Ca++
PMCA1B
Lumen Blood
-10 mV
Mg++
TRPM6
28. All the following are true aboutAll the following are true about
neonatal Bartter syndrome EXCEPTneonatal Bartter syndrome EXCEPT
A) Presents in neonatal period.
B) Associated with nephrocalcinosis.
C) Associated with oligohydraminos.
D) May be associated with deafness.
29.
30. BS Type I BS Type IIIBS Type I BS Type III GSGS
• Age at presentationAge at presentation NeonatalNeonatal ≤ 2 years old≤ 2 years old
• Growth retardationGrowth retardation SevereSevere Mild-moderateMild-moderate
• PolyuriaPolyuria PresentPresent PresentPresent May be presentMay be present
• NephrocalcinosisNephrocalcinosis PresentPresent +/-+/-
• PolyhydramniosPolyhydramnios PresentPresent May be presentMay be present
• ChondrocalcinosisChondrocalcinosis AbsentAbsent AbsentAbsent May be presentMay be present
• Carpal pedal spasmCarpal pedal spasm AbsentAbsent AbsentAbsent May be presentMay be present
• SN Hearing LossSN Hearing Loss May be presentMay be present AbsentAbsent AbsentAbsent
Clinical picture ….Clinical picture ….
Absent or mildAbsent or mild
AbsentAbsent
AbsentAbsent
Above 5 yearsAbove 5 years
31. BS Type I BS Type IIIBS Type I BS Type III GSGS
• HypokalemiaHypokalemia PresentPresent PresentPresent PresentPresent
• Metabolic alkalosisMetabolic alkalosis PresentPresent PresentPresent PresentPresent
• HyperreninemiaHyperreninemia PresentPresent PresentPresent PresentPresent
• HyperaldosteronemiaHyperaldosteronemia PresentPresent PresentPresent PresentPresent
• Urinary calciumUrinary calcium Very HighVery High HighHigh
• HypomagnesemiaHypomagnesemia Absent or mildAbsent or mild Absent or mildAbsent or mild
• Urinary prostaglandinsUrinary prostaglandins HighHigh HighHigh
Biochemical markers ….Biochemical markers ….
LowLow
PresentPresent
NormalNormal
32. Back to Our PatientBack to Our Patient
Urinary Ca: 6 mg/kg/d
Serum Mg: 2 mEq/ml
35. BS Type I BS Type III GS
• Oral K supplements Usually required Usually required Usually required
• K sparing diuretics Indicated Indicated Indicated
• NSAIDs Used with caution Indicated Not indicated
• NaCl Usually required Recommend Recommend
• ACE-inhibitors Indicated Indicated Indicated
• Oral Mg supplements Not required Not required Usually required
• Growth Hormone May be beneficial May be beneficial May be beneficial
Treatment ….
38. O Hypokalemic metabolic alkalosis is not an
uncommon disorder among children.
O Patients are often asymptomatic but they
may develop serious neurologic or
respiratory symptoms.
39. O Do not forget to exclude hypokalemic
metabolic alkalosis on dealing with a case of
unexplained paresis or paralysis.
O The golden point during dealing with
hypokalemia is not giving K supplementation,
but knowing the cause to treat it.
Generating the lumen-positive electrical charge that drives the paracellular reabsorption of Na+, Ca2+ and Mg2+ in this segment(
Na absorption depends on NKCC2 with about half of the sodium taking the transcellular route and half taking a paracellular route by cation selective intercellular pathways.
The absorbed Na—via counter-current multiplication—contribute to medullary interstitial hypertonicity which is the osmotic driving force for water absorption along CD.
All Cl is absorbed through transcellular route.
K which enter through NKCC2 recycles back to the tubular urine through renal outer medullary potassium (ROMK) channels.
Luminal K secretion in addition establishes a lumen positive transepithelial voltage gradient that provides a driving force for paracellular transport of cations like sodium, calcium, and magnesium.
Basolateral sodium release from the cell is by the sodium pump.
basolateral chloride exit by two highly homologous ClC-K-type chloride channel proteins (ClC-Ka and ClC-Kb) associate with their beta subunit barttin.
Generating the lumen-positive electrical charge that drives the paracellular reabsorption of Na+, Ca2+ and Mg2+ in this segment(
Na absorption depends on NKCC2 with about half of the sodium taking the transcellular route and half taking a paracellular route by cation selective intercellular pathways.
The absorbed Na—via counter-current multiplication—contribute to medullary interstitial hypertonicity which is the osmotic driving force for water absorption along CD.
All Cl is absorbed through transcellular route.
K which enter through NKCC2 recycles back to the tubular urine through renal outer medullary potassium (ROMK) channels.
Luminal K secretion in addition establishes a lumen positive transepithelial voltage gradient that provides a driving force for paracellular transport of cations like sodium, calcium, and magnesium.
Basolateral sodium release from the cell is by the sodium pump.
basolateral chloride exit by two highly homologous ClC-K-type chloride channel proteins (ClC-Ka and ClC-Kb) associate with their beta subunit barttin.
DCT1 cells express an apical magnesium conductance (TRPM6), whereas DCT2 cells provide an apical calcium conductance formed by ECaC (TRPV5). Impairment of DCT1 cell function by mutations of NCCT or ClC-Kb might shift the DCT1/DCT2 cell ratio in favor of DCT 2 cells, resulting in increased magnesium and decreased calcium excretion.
2 types of cells are present DCT1, DCT2.
NaCl absorption in the DCT1 occurs almost exclusively by the transcellular route mediated by the sodium chloride co-transporter NCCT.
The absorbed Na does not contribute to the urinary concentrating mechanisms.
No apical K conductance
TRPM6 allow apical conductance of Mg
The basolateral conductance of Na and Cl is the same as TAL.
DCT2 express apical epithelial Na channel(e Na c) and apical conductance of Ca by E Ca C (TRPV5).